Medications

Report: Remdesivir dominated hospital drug spending in 2021

The COVID-19 treatment remdesivir dominated hospital drug spending in 2021, accounting for nearly 10% of all pharmaceutical expenses and outpacing the next three drugs combined, according to the National Trends in Prescription ...

Diseases, Conditions, Syndromes

US rushes to catch up in the race to detect mutant viruses

Despite its world-class medical system and its vaunted Centers for Disease Control and Prevention, the U.S. fell behind in the race to detect dangerous coronavirus mutations. And it's only now beginning to catch up.

Medical economics

Expanding Medicaid in holdout states could insure 3.9 million

(HealthDay)—Expanding Medicaid to all states could reduce the number of uninsured by 28 percent based on pre-COVID-19 data, according to a report released by the Urban Institute and the Robert Wood Johnson Foundation.

Medical economics

Estimating spending on COVID-19

In a new report published by the Brookings Institution, Matthew Fiedler, a fellow in economic studies at the USC-Brookings Schaeffer Initiative for Health Policy, and Zirui Song, assistant professor of health care policy ...

page 1 from 2